Status:
COMPLETED
Changes in Eye Pressure and Anterior Chamber Depth With Oral Endothelin Antagonist Therapy
Lead Sponsor:
University of Colorado, Denver
Conditions:
Glaucoma
Pulmonary Hypertension
Eligibility:
All Genders
18-80 years
Brief Summary
There is growing evidence that a cause of glaucoma is linked to circulatory problems and poor auto-regulation of blood flow to the optic nerve. Pulmonary hypertension (PH)is a disease characterized by...
Eligibility Criteria
Inclusion
- diagnosed with pulmonary hypertension
- between the ages of 18 and 80 years
- ability to undergo the various ocular exams.
Exclusion
- patients with other diseases that could affect the nerve fiber layer
- special populations; ie children, pregnancy, lactating females, prisoners
Key Trial Info
Start Date :
March 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT00452283
Start Date
March 1 2007
End Date
May 1 2011
Last Update
January 31 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado Eye Center
Aurora, Colorado, United States, 80045